RecruitingNot ApplicableNCT05995496

Changes in Inhibition and Valuation After Eating

Dynamic Neural Computations Underlying Cognitive Control in Bulimia Nervosa


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

150 participants

Start Date

Dec 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

An impaired ability to exert control has been implicated in bulimia nervosa (BN), but this impairment may not represent a stable trait or be the most effective focus for treatment. This project aims to understand how predictions and value-based decisions about control may be abnormally influenced by eating in individuals with BN, thereby maintaining cycles of binge eating, purging, and restriction.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria6

  • Female
  • Aged 18 to 45 years
  • Current BMI greater than or equal to 18.5kg/m2 but under 30kg/m2
  • Right-handed
  • English-speaking
  • Meet DSM-5 criteria for bulimia nervosa

Exclusion Criteria6

  • Medical instability
  • Ongoing medical treatment, medical condition, or psychiatric disorder that may interfere with study variables or participation
  • Shift work
  • Pregnancy, planned pregnancy, or lactation during the study period
  • Allergy to any of the ingredients in or unwillingness to consume the standardized meal or unwillingness to drink water during the fasting period
  • Any contraindication for fMRI

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFasting state

16 hours of fasting

OTHERFed state

Fed a standardized meal

OTHERMagnetic Resonance Imaging

Neuroimaging with computational modeling


Locations(1)

Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05995496


Related Trials